BRISTOL MYERS SQUIBB CO

BMY · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $121.1B · 32,500 employees
165
SEC Filings
$58.62
Close 2026-04-10
5
Transcripts
32,500
Employees

Business Summary

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases including cancer, cardiovascular conditions, immunology, and fibrosis. Key marketed products include Revlimid, Eliquis, Opdivo, Pomalyst, Orencia, Sprycel, Yervoy, Abraxane, and Empliciti. The company engages in extensive R&D, strategic alliances, licensing arrangements, and global manufacturing to bring therapies to patients worldwide.

Latest Stock Quote

BMY 2026-04-10 $58.62 O:$59.79 H:$59.8 L:$58.46 Vol:8.1M VWAP:$58.74
origin leaf: c0b0db9d88c63ccfbac78c5e06624fec123a7ae306b699dbfc7d16f88e2acbdc

Next Earnings

Q2 FY2026 — expected 2026-07-26

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBMYdiscussed Artificial Intelligence
topic_mentionBMYdiscussed Artificial Intelligence
topic_mentionBMYdiscussed Blockchain & Crypto
topic_mentionBMYdiscussed Regulation
topic_mentionBMYdiscussed Healthcare & Bio
topic_mentionBMYdiscussed Artificial Intelligence
topic_mentionBMYdiscussed Blockchain & Crypto
topic_mentionBMYdiscussed Autonomous Vehicles
topic_mentionBMYdiscussed Supply Chain
topic_mentionBMYdiscussed Regulation
topic_mentionBMYdiscussed Sovereign & Government
topic_mentionBMYdiscussed Automotive
topic_mentionBMYdiscussed Healthcare & Bio
metricBMY EPSreported $6.05
topic_mentionBMYdiscussed Blockchain & Crypto
topic_mentionBMYdiscussed Regulation
topic_mentionBMYdiscussed Sovereign & Government
topic_mentionBMYdiscussed Automotive
topic_mentionBMYdiscussed Healthcare & Bio
metricBMY EPSreported $6.05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310000014272-26-000004EDGAR86K words
2025-02-122024-12-310000014272-25-000039EDGAR—
2024-02-132023-12-310000014272-24-000044EDGAR—
2023-02-142022-12-310000014272-23-000046EDGAR—
2022-02-092021-12-310000014272-22-000051EDGAR—
2021-02-102020-12-310000014272-21-000066EDGAR—
2020-02-242019-12-310000014272-20-000082EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300000014272-25-000149EDGAR31K words
2025-07-312025-06-300000014272-25-000131EDGAR—
2025-04-242025-03-310000014272-25-000091EDGAR—
2024-10-312024-09-300000014272-24-000147EDGAR—
2024-07-262024-06-300000014272-24-000123EDGAR—
2024-04-252024-03-310000014272-24-000096EDGAR—
2023-10-262023-09-300000014272-23-000181EDGAR—
2023-07-272023-06-300000014272-23-000152EDGAR—
2023-04-272023-03-310000014272-23-000104EDGAR—
2022-10-262022-09-300000014272-22-000196EDGAR—
2022-07-272022-06-300000014272-22-000166EDGAR—
2022-04-292022-03-310000014272-22-000114EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-050000014272-26-000002EDGAR17K words
2026-01-120001140361-26-000929EDGAR—
2025-11-180001140361-25-042607EDGAR—
2025-11-100001140361-25-041380EDGAR—
2025-11-030001140361-25-040066EDGAR—
2025-10-300000014272-25-000147EDGAR—
2025-07-310000014272-25-000129EDGAR—
2025-07-250001140361-25-027350EDGAR—
2025-05-070001140361-25-017742EDGAR—
2025-04-240000014272-25-000089EDGAR—

165 total filings indexed. 136 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— BMY Earnings Call Transcript
— BMY Earnings Call Transcript
—Q4 FY2025BMY Q4 FY2025 Earnings Call Transcript
—Q1 FY2026BMY Q1 FY2026 Earnings Call Transcript
—Q4 FY2025BMY Q4 FY2025 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology cardiovascular immunology fibrosis hematology

Company Identity

CIK0000014272
TickerBMY
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.bms.com
Listed1952-06-23

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 2e89e37c4c152cd961dd1f7ba2ae6f9f4d256564016960cee254ceeb9003e865
parent: 2756eb8df1b141e748a2987c075b98e29a441b4d84cd46e96c0f20a578a15dc6
content hash: 77c8fe9fad39d77fc801111379d2395f0fadfd93f120680869af2c5da48f5219
signed: 2026-04-13T04:44:02.505Z
sources: 25 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf